Puma Biotechnology, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $8.2M | $-3.8M | $13.4M | $8.8M | $5.9M | $3.0M | $19.3M | $20.3M |
| Depreciation & Amortization | $2.5M | $2.6M | $2.7M | $2.7M | $2.8M | $2.8M | $2.8M | $2.9M |
| Depreciation | $0 | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K |
| Amortization | $2.4M | $2.4M | $2.5M | $2.4M | $2.4M | $2.4M | $2.5M | $2.4M |
| Stock-Based Compensation | $2.0M | $1.9M | $1.6M | $1.7M | $1.6M | $2.0M | $1.8M | $2.1M |
| Net Cash from Operating Activities | $1.6M | $15.4M | $14.4M | $9.7M | $14.1M | $3.6M | $15.6M | $11.0M |
| Investing Activities | ||||||||
| Capital Expenditures | $0 | $0 | $-36.0K | $26.0K | $20.0K | $61.0K | $16.0K | $20.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $8.0M | $2.5M | $-27.0M | $506.0K | $-11.2M | $1.5M | $-2.3M | $259.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-11.3M | $-11.3M | $-11.3M | $-11.3M | $-11.2M | $-11.3M | $-11.3M | $-11.2M |
| Net Change in Cash | $-1.7M | $6.6M | $-23.9M | $-1.1M | $-8.4M | $-6.2M | $2.0M | $114.0K |
| Free Cash Flow | $1.6M | $15.4M | $14.5M | $9.7M | $14.1M | $3.6M | $15.6M | $11.0M |